Moderna Inc



+69.4% last 12 months

Market Cap

$85.2 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$117.34 - $497.49

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio


The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $85.2 Billion
Enterprise Value $76.8 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return +69.4%
52-Week High $497.49
52-Week Low $117.34
Beta 0.38
Outstanding Shares 405 Million
Avg 30 Day Volume 9.63 Million


P/E Ratio 12.07
PEG -0.79
Earnings per Share $16.69
Price to Sales Ratio 7.06
Price to Book Ratio 8.53
Revenue to Enterprise Value 6.49
EBIT to Enterprise Value 10.09
Total Debt to Enterprise Value 0.01
Debt to Equity 0.05


Revenue $11.8 Billion
Gross Profit $10.2 Billion
EBIT $7.61 Billion
Net Income $7.06 Billion
Profit Margin 59.69%
Quarterly Earnings Growth (YoY) -1526.6%
Return on Equity 69.75%
Return on Assets 33.75%
Return on Invested Capital 69.41%

Insider trades

No purchases

262,865 shares sold (44 transactions)

No purchases

229,208 shares sold (28 transactions)

No purchases

238,450 shares sold (30 transactions)

No purchases

20,000 shares sold (2 transactions)

Q2 2021 Q3 2021 Q4 2021 Q1 2022

About Moderna Inc

CEO: Stephane Bancel

Industry: Biological Product (except Diagnostic) Manufacturing

Similar stocks

Merck & Co Inc
Merck & Co Inc
Athersys Inc
Athersys Inc
Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
Novartis AG - ADR
Novartis AG - ADR
Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Johnson & Johnson
Johnson & Johnson
Dicerna Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc